ACTR-88. A PHASE II STUDY OF THE EFFICACY OF HYPOFRACTIONATED RADIATION THERAPY WITH BEVACIZUMAB AND TEMOZOLOMIDE FOLLOWED BY MAINTENANCE TEMOZOLOMIDE AND BEVACIZUMAB FOR RECURRENT HIGH-GRADE GLIOMAS

BACKGROUND: Patients with recurrent high grade glioma (rHGG) have a poor prognosis with limited treatment options, especially those refractory to bevacizumab. A phase II multi-center trial was performed to determine the overall survival (OS) of hypofractioned radiation with concurrent bevacizumab (B...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Dixit, Karan, Kumthekar, Priya, Kruser, Timothy, Sachdev, Sean, Kalapurakal, John A, Gondi, Vinai, Grimm, Sean, Nicholas, Martin, Lukas, Rimas V, Chmura, Steven J, Mehta, Minesh P, Raizer, Jeffrey
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2017
Assuntos:
Abstracts
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692374/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.073
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares